ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease

Completed · Phase 2

Conditions studied: Alzheimer's Disease

In brief

The purpose of this study is to evaluate the long-term safety and tolerability of ELND005 beyond the 18 months of treatment in original randomized and blinded clinical trail ELND005-AD201.

Key facts

Study ID

NCT00934050

Run by

OPKO Health, Inc.

People needed

103

Starts

2009-06-01

Expected to finish

2011-06-01

Last updated by the study team

2019-10-21

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• This study is open only to subjects who have completed the week 78 visit in Study ELND005-AD201 while taking their assigned dose of study drug medication.

You may not qualify if…

• Subject has no new medical contraindications to continued participation in the study.

Where it is running

• Banner Alzheimer's Institute — Phoenix, Arizona, United States
• Sun Health Research Institute — Sun City, Arizona, United States
• University of Arizona, Health Sciences Center, Dept. of Neurology — Tucson, Arizona, United States
• Margolin Brain Institute — Fresno, California, United States
• Collaborative NeuroScience Network, Inc. — Garden Grove, California, United States
• Yale University School of Medicine, Alzheimer's Disease Research Unit — New Haven, Connecticut, United States
• Brain Matters Research — Delray Beach, Florida, United States
• Sunrise Clinical Research, Inc — Hollywood, Florida, United States
• Roskamp Institute — Sarasota, Florida, United States
• Premiere Research Institute — West Palm Beach, Florida, United States
• Emory University, Dept. of Neurology — Atlanta, Georgia, United States
• Dekalb Neurology Associates, LLC — Decatur, Georgia, United States
• Department of Neurology - Indiana University Medical Center — Indianapolis, Indiana, United States
• University of Kansas Medical Center, Department of Neurology — Kansas City, Kansas, United States
• Innovative Clinical Concepts — Paducah, Kentucky, United States
• Memory Enhancement Center of America, Inc. — Eatontown, New Jersey, United States
• Global Medical Institutes — Princeton, New Jersey, United States
• Albuquerque Neuroscience, Inc. — Albuquerque, New Mexico, United States
• Neurological Associates of Albany, PC — Albany, New York, United States
• Columbia University Sergievsky Center — New York, New York, United States
• AD-CARE, Monroe Community Hospital — Rochester, New York, United States
• Raleigh Neurology Associates — Raleigh, North Carolina, United States
• Neurology & Neuroscience Center of Ohio — Toledo, Ohio, United States
• Medford Neurological and Spine Clinic — Medford, Oregon, United States
• Summit Research Newtwork, Inc. — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.